BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment

被引：3
|
作者：
Niederer, Fabienne [1 ]
Scherer, Almut [2 ]
Kyburz, Diego [3 ]
Gay, Renate E. [1 ]
Gay, Steffen [1 ]
Michel, Beat A. [3 ]
Ciurea, Adrian [3 ]
机构：
[1] Univ Zurich Hosp, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Rheumatol, CH-8091 Zurich, Switzerland
来源：
JOINT BONE SPINE | 2013年 / 80卷 / 04期
关键词：
Ankylosing spondylitis; BAFF; BLyS; Anti-tumor necrosis factor treatment; RHEUMATOID-ARTHRITIS; DISEASES; THERAPY;
D O I：
10.1016/j.jbspin.2012.10.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：433 / 434
页数：2
相关论文
共 50 条
  • [1] Body Composition in Patients with Ankylosing Spondylitis on Anti-Tumor Necrosis Factor Alpha Treatment
    Sahin, Ozlem
    Kaptanoglu, Ece
    Dinler, Mustafa
    Dogan, Sevil Ceyhan
    Kurt, Kibar Gultekin
    [J]. KUWAIT MEDICAL JOURNAL, 2017, 49 (02): : 142 - 147
  • [2] Effects of Anti-tumor Necrosis Factor Treatment on Lipid Profiles in Patients with Ankylosing Spondylitis
    Kwon, Inbeom
    Nam, bora
    Choi, Nayeon
    Shin, Ji-Hui
    Lee, Seunghun
    Kim, Tae-Hwan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1044 - 1046
  • [3] Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis
    Kwon, Inbeom
    Choi, Nayeon
    Shin, Ji Hui
    Lee, Seunghun
    Nam, Bora
    Kim, Tae-Hwan
    [J]. JOURNAL OF RHEUMATIC DISEASES, 2024, 31 (01): : 41 - 48
  • [4] Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis
    Lee, Jeong-Won
    Kang, Ji-Hyoun
    Yim, Yi-Rang
    Kim, Ji-Eun
    Wen, Lihui
    Lee, Kyung-Eun
    Park, Dong-Jin
    Kim, Tae-Jong
    Park, Yong-Wook
    Lee, Shin-Seok
    [J]. PLOS ONE, 2015, 10 (07):
  • [5] The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment
    Nam, Bora
    San Koo, Bon
    Choi, Nayeon
    Shin, Ji-Hui
    Lee, Seunghun
    Bin Joo, Kyung
    Kim, Tae-Hwan
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [6] Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
    Tong, Qiang
    Cai, Qing
    de Mooij, Tristan
    Xu, Xia
    Dai, Shengming
    Qu, Wenchun
    Zhao, Dongbao
    [J]. PLOS ONE, 2015, 10 (03):
  • [7] Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor α monoclonal antibody infliximab
    Brandt, J
    Haibel, H
    Cornely, D
    Golder, W
    Gonzalez, J
    Reddig, J
    Thriene, W
    Sieper, J
    Braun, J
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1346 - 1352
  • [8] Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Rudwaleit, M.
    Sieper, J.
    Braun, J.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S14 - S14
  • [9] Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    X Baraliakos
    J Listing
    J Brandt
    M Rudwaleit
    J Sieper
    J Braun
    [J]. Arthritis Research & Therapy, 7
  • [10] Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
    Barallakos, X.
    Brandt, J.
    Listing, J.
    Sieper, J.
    Braun, J.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S14 - S14
12345